Search

everythinglearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A new method was developed to make finasteride for treating hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Blocking certain brain processes reduces mating behavior in female rats.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

New progesterone-based compounds can block male hormones.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

A new method to make Finasteride is more cost-effective and yields 16%.

Progesterone and its metabolites can prevent seizures without major side effects.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

LC-MS/MS is essential for accurately detecting pregnanes in pregnant mares.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Canine hair follicle cells convert progesterone into various metabolites, mainly cortisol.